Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce
gender incongruence and improve psychological functioning. As GAHT shares many …

Transgender (trans) women (TW) were assigned male at birth but have a female gender
identity or gender expression. The literature on management and health outcomes of TW …

Transgender men and women represent about 0.6-1.1%% of the general population.
Gender affirming hormone therapy (GAHT) helps ameliorate gender dysphoria and promote …

Aims Feminizing gender‐affirming hormone therapy (GAHT) can be utilized to help
transfeminine transgender and gender diverse (TGD) individuals achieve the transformation …

With the growing number of transgender and gender-nonbinary individuals who are
becoming visible, it is clear that there is a need to develop a rigorous evidence base to …

Transgender men and women represent a growing population in the United States and
Europe, with 0.5% of adults and 3% of youth identifying as transgender. Globally, an …

Importance Gender-affirming hormone treatment (GAHT) is a common therapy for
transgender individuals to reduce gender dysphoria and improve quality of life. Clarifying …

Gender-affirming treatment of transgender people requires a multidisciplinary approach in
which endocrinologists play a crucial role. The aim of this paper is to review recent data on …

Transgender individuals often face elevated mental health challenges due to gender
dysphoria, but gender-affirming treatments such as surgery and hormone therapy have been …

Gender-affirming hormone treatment generally by cross-sex hormones is an important
strategy for transgender people to achieve the physical features affirming their experienced …